Price target
2.492DEUR+1.6805+207.21%
The 5 analysts offering 1 year price forecasts for PHARMING GROUP have a max estimate of 3.594 and a min estimate of 1.401.
Analyst rating
Based on 5 analysts giving stock ratings to PHARMING GROUP in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
5
Buy
0
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.02
−0.01
−0.01
0.00
0.01
Reported
Estimate
Currency: EUR
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.00
0.00
0.00
−0.02
0.00
0.00
0.00
—
—
—
—
Estimate
−0.01
−0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Surprise
+110.34%
+103.85%
−988.89%
−2,814.29%
−900.00%
−700.00%
+163.16%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
25.00 M
50.00 M
75.00 M
100.00 M
Reported
Estimate
Currency: EUR
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
50.33 M
63.10 M
73.57 M
51.53 M
69.18 M
67.23 M
89.55 M
—
—
—
—
Estimate
48.80 M
58.34 M
65.07 M
63.42 M
67.16 M
69.09 M
78.49 M
63.09 M
73.53 M
79.81 M
88.12 M
Surprise
+3.14%
+8.16%
+13.05%
−18.74%
+3.01%
−2.71%
+14.09%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PHARM EPS for the last quarter is 0.00 EUR despite the estimation of 0.00 EUR. In the next quarter EPS is expected to reach −0.00 EUR. Track more of PHARMING GROUP financials and stay on top of what is up with the company.
In the next quarter PHARMING GROUP revenue is expected to reach 63.09 M EUR. Check out PHARMING GROUP revenue and earnings and make informed decisions.
According to analysts, PHARM price target is 2.49 EUR with a max estimate of 3.59 EUR and a min estimate of 1.40 EUR. Check if this forecast comes true in a year, meanwhile watch PHARMING GROUP stock price chart and keep track of the current situation with PHARM news and stock market news.
We've gathered opinions of 5 analysts rating PHARM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.